Month: September 2024

The pressing issue of Post-Traumatic Stress Disorder (PTSD) in the United States, affecting 13 million citizens including a substantial number of women and veterans, highlights a critical area of concern in healthcare. PTSD, triggered by traumatic experiences ranging from assault to natural disasters, has shown that current standard-of-care therapies are insufficient for many, with approximately […]

Continue Reading

Dr. Eve Cunningham, Chief of Virtual Care and Digital Health at Providence, highlighted several pressing issues faced by health professionals today during her interview at the INVEST Digital Health conference. As an OB-GYN specialist, she discussed the overwhelming nature of the Electronic Medical Record (EMR) system. Originally, patient charts comprised a mere folder with a […]

Continue Reading

Heart disease has been the top cause of mortality in the United States for over a century, despite significant advancements in understanding and treating this complex condition. Although there are numerous treatment options available that can minimize the risk of severe cardiovascular incidents such as heart attacks or strokes, there is a persistent issue with […]

Continue Reading

Organon is expanding its presence in the dermatology sector through an acquisition of Dermavant, a subsidiary of Roivant Sciences, primarily focusing on a commercialized plaque psoriasis treatment that may soon be applicable to atopic dermatitis, a more common inflammatory skin condition. Organon’s deal could total up to $1.2 billion, with an upfront payment of $175 […]

Continue Reading

Zevra Therapeutics recently received FDA approval for its drug Miplyffa, marking a significant development as it becomes the first approved therapy for Niemann-Pick disease type C (NPC), a severe and often fatal metabolic disorder. This approval is particularly impactful as NPC, a rare inherited condition, affects the central nervous system and can lead to death […]

Continue Reading

GE Healthcare recently announced that it has gained 510(k) clearance for a new diagnostic tool aimed at aiding in the assessment of Alzheimer’s disease. This tool incorporates a Centiloid scale into GE Healthcare’s Mim software, enhancing the ability of clinicians to quantify the density of amyloid plaque from PET scans in patients’ brains. Amyloid plaques, […]

Continue Reading

Some users of the Freestyle Libre 3 glucose sensor, a product by Abbott, are currently experiencing delays in getting their prescriptions filled. The delays are primarily due to a significantly high demand for the Libre 3 sensors, according to Abbott spokesperson Lindsy Delco. She explained that the company is actively enhancing production capacities to meet […]

Continue Reading

The Food and Drug Administration (FDA) has appointed Ross Segan, a former industry executive with a background at Olympus and also an Army veteran, as the head of the division responsible for ensuring the safety of medical devices. This decision comes as significant, considering Segan’s recent tenure as Chief Medical Officer at Olympus from 2020 […]

Continue Reading

Elon Musk’s Neuralink, a startup focused on developing brain-computer interfaces (BCIs), has recently been granted FDA Breakthrough Device Designation for its new product, Blindsight. Blindsight is an innovative implant designed to restore vision for individuals who are blind, targeting the visual cortex in the brain. The core function of Blindsight involves implanting a microelectrode array […]

Continue Reading

The MedCity News INVEST Digital Health Conference in Dallas brought together executives from the direct-to-consumer medical testing industry, who discussed the challenges and opportunities in this growing field. Robert Weigle, CEO of NOWDiagnostics, highlighted the difficulties in obtaining funding and FDA clearance. He emphasized the complexity and high costs associated with developing diagnostic tests, noting […]

Continue Reading